The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

The importance of this technique becomes even clearer when considering the larger context. An astonishing 100 million ...

She would have periods in time where she’d suddenly wake up in the middle of the day and she couldn’t remember anything from ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

Researchers have developed a revolutionary magnetogenetics technology that can control brain circuits non-invasively using ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

PS makes wellness more accessible through real-life stories, first-person perspectives, and expert-backed information. Our ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.